Results 91 to 100 of about 8,703 (161)

Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches

open access: yesInfection and Drug Resistance, 2021
Anna Maria Tortorano,1 Anna Prigitano,1 Gianluca Morroni,2 Lucia Brescini,2,3 Francesco Barchiesi2,4 1Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy; 2Department of Biomedical Sciences and Public Health ...
Tortorano AM   +4 more
doaj  

Development of Echinocandin Resistance in Candida haemulonii: An Emergent, Widespread, and Opportunistic Fungal Pathogen. [PDF]

open access: yesJ Fungi (Basel), 2023
Silva LN   +8 more
europepmc   +1 more source

Novel Non-Hot Spot Modification in Fks1 of Candida auris Confers Echinocandin Resistance. [PDF]

open access: yesAntimicrob Agents Chemother, 2023
Kordalewska M   +6 more
europepmc   +1 more source

Micafungin microevolution in Candida auris reveals resistance development without in vivo fitness compromise

open access: yesVirulence
Candida auris is an emerging multidrug-resistant pathogen with high transmissibility in healthcare settings. Although echinocandin resistance in Candida is typically associated with fitness loss, we found that micafungin-resistant C.
Flora Bohner   +5 more
doaj   +1 more source

Echinocandin Resistance in Candida auris Occurs in the Murine Gastrointestinal Tract Due to FKS1 Mutations. [PDF]

open access: yesAntimicrob Agents Chemother, 2023
Hirayama T   +14 more
europepmc   +1 more source

Tn-seq screens in Candida glabrata treated with echinocandins and ibrexafungerp reveal pathways of antifungal resistance and cross-resistance

open access: yesmSphere
Candida glabrata (also known as Nakaseomyces glabratus) is the second most common cause of candidiasis, next to Candida albicans, and is rising in prevalence due to intrinsic and acquired mechanisms of antifungal resistance.
Timothy J. Nickels, Kyle W. Cunningham
doaj   +1 more source

A pan-azole and pan-echinocandin resistant Wickerhamomyces anomalus isolate causing bloodstream infection: ERG11Y140F, K151R with copy number variation and FKS1 F665S mutation

open access: yesInternational Journal of Medical Microbiology
Fungal infections pose a growing global threat, particularly due to the emergence of multidrug-resistant pathogens. This study reports the first globally documented case of a Wickerhamomyces anomalus isolate (XN272) displaying dual high-level resistance ...
Zhengyu Luo   +17 more
doaj   +1 more source

Mechanisms of multidrug resistance caused by an Ipi1 mutation in the fungal pathogen Candida glabrata

open access: yesNature Communications
Multidrug resistance in the pathogenic fungus Candida glabrata is a growing global threat. Here, we study mechanisms of multidrug resistance in this pathogen. Exposure of C.
Taiga Miyazaki   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy